Studies of Transfer RNA
转移RNA的研究
基本信息
- 批准号:9895829
- 负责人:
- 金额:$ 103.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-04-01 至 2022-03-31
- 项目状态:已结题
- 来源:
- 关键词:Amino AcidsAmino Acyl Transfer RNAAmino Acyl-tRNA SynthetasesApoptosisAreaBiochemicalBioinformaticsBiologicalBiologyBiophysicsBiotechnologyCell physiologyCellsChemicalsCodeCodon NucleotidesComplexDNADevelopmentDiseaseElementsElongation FactorEngineeringEnzymesEvolutionExhibitsGene ExpressionGeneticGenetic CodeGenetic DiseasesGoalsHealthHumanIndustrializationKnowledgeLinkMalignant NeoplasmsMedicalMetabolic DiseasesMolecularNatureNeurodegenerative DisordersOrganismPharmacologyPhosphoamino AcidsPhosphorylationPhosphoserinePost-Translational Protein ProcessingProcessProductionProtein EngineeringProteinsRNA, Transfer, Amino Acid-SpecificResearch PersonnelRibosomesRoleRouteSalvelinusSeleniumSelenocysteineSeriesSignal TransductionSiteStructureSystemTrace ElementsTransfer RNATranslationsWorkanalogbasecancer cellcancer geneticschemical propertydesignfrontierhuman diseaseinnovationinterestkinase inhibitornovelnovel therapeutic interventionprotein functionsuccesstargeted treatmenttool
项目摘要
PROJECT SUMMARY
Proteins are typically synthesized with 20 amino acids, yet over 300 amino acids are found in proteins as a result
of posttranslational modifications (PTMs). These natural noncanonical amino acids (ncAAs) modulate protein
function and control fundamental cellular processes. Satisfactory genetic encoding of ncAAs requires the
development of efficient and accurate aminoacyl-tRNA formation and delivery to the ribosome by design of
tRNAs, tRNA synthetases, and elongation factors that constitute orthogonal translation systems (OTSs). While
some ncAAs have been genetically encoded (e.g., N-acetyllysine, phosphoserine (Sep)), OTSs have not been
established for a number of critical PTMs. The overall goal of this proposal is to rewire translation by developing
OTSs for facile and precise production of natural and engineered proteins containing naturally occurring and
synthetic ncAAs.
These general goals will be realized in three specific areas of the proposed work. (1) Selenium, in the form
of selenocysteine (Sec), is an essential trace element for human health, exhibiting many advantageous chemical
properties with its misincorporation implicated in many disease states. We will engineer efficient site-directed
insertion of Sec and investigate the effects its insertion along with its precursor Sep into several enzymes of
industrial and medical interest. (2) While the genetic code was once thought to be universal, natural codon
reassignments in nature are now known to be widespread. We will couple bioinformatic analysis with our
knowledge of tRNA identity elements to both reveal novel genetic codes and better characterize the role of this
variability in nature. Additionally, we will use long-term evolution to produce an organism with a new genetic code
utilizing synthetic amino acids. (3) We plan to create aminoacyl-tRNA synthetases for efficient synthesis of ncAA-
tRNA for a series of phosphoamino acids and chemically reactive synthetic amino acids. Given the critical role
of phosphorylation in cell signaling and the success of kinase inhibitors against cancer cells, and based on our
success establishing an OTS for phosphoserine, we propose to establish OTSs for additional phosphoamino
acids and their non-hydrolyzable analogs. Incorporation of chemically reactive amino acids will provide a robust
tool to introduce PTMs, biophysical probes, or other valuable residues into a protein of interest.
The proposed work is significant because the ability to produce, purify, biochemically and structurally char-
acterize proteins containing ncAAs at defined sites is essential for elucidation of fundamental cellular processes
and for construction of new tools for protein design. The innovation of the proposed work is to genetically encode
these biologically relevant ncAAs, and provide efficient OTSs for biochemical and biomedical researchers to help
unravel the complex network of PTMs and their role in biotechnology and human health.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DIETER SOLL其他文献
DIETER SOLL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DIETER SOLL', 18)}}的其他基金
ARCHAEAL 3'-PHOSPHATE RNA SPLICING LIGASE CHARACTERIZATION
古菌 3-磷酸 RNA 剪接连接酶表征
- 批准号:
8365789 - 财政年份:2011
- 资助金额:
$ 103.4万 - 项目类别:
SERYL-TRNA SYNTHETASES: EVOLUTION AND DIVERSITY
Seryl-TRNA 合成酶:进化和多样性
- 批准号:
6499499 - 财政年份:2001
- 资助金额:
$ 103.4万 - 项目类别:
SERYL-TRNA SYNTHETASES: EVOLUTION AND DIVERSITY
Seryl-TRNA 合成酶:进化和多样性
- 批准号:
6288388 - 财政年份:2001
- 资助金额:
$ 103.4万 - 项目类别:
SERYL-TRNA SYNTHETASES: EVOLUTION AND DIVERSITY
Seryl-TRNA 合成酶:进化和多样性
- 批准号:
6629366 - 财政年份:2001
- 资助金额:
$ 103.4万 - 项目类别:
EVOLUTION OF ESSENTIAL TRANSLATIONAL PATHWAYS IN ARCHAEA
古生菌基本翻译途径的进化
- 批准号:
6342938 - 财政年份:1998
- 资助金额:
$ 103.4万 - 项目类别:
EVOLUTION OF ESSENTIAL TRANSLATIONAL PATHWAYS IN ARCHAEA
古生菌基本翻译途径的进化
- 批准号:
2857291 - 财政年份:1998
- 资助金额:
$ 103.4万 - 项目类别:
EVOLUTION OF ESSENTIAL TRANSLATIONAL PATHWAYS IN ARCHAEA
古生菌基本翻译途径的进化
- 批准号:
6138562 - 财政年份:1998
- 资助金额:
$ 103.4万 - 项目类别:














{{item.name}}会员




